Terms: = Liver cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
31 results:
1. rarRES1 inhibits hepatocellular carcinoma progression and increases its sensitivity to lenvatinib through interaction with SPINK2.
Guo Y; Chai B; Zhang H; Chai X; Chen Y; Xu J; Qin L; Chai Y
Biol Direct; 2024 Feb; 19(1):15. PubMed ID: 38388961
[TBL] [Abstract] [Full Text] [Related]
2. Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas.
Warda A; Staniszewski LJP; Sabir Z; Livingston S; Sausedo M; Reshi S; Ron E; Applegate MT; Haddad D; Khamisi M; Marshall PA; Wagner CE; Jurutka PW
Cells; 2023 Nov; 12(21):. PubMed ID: 37947652
[TBL] [Abstract] [Full Text] [Related]
3. Targeting the Retinoic Acid Pathway to Eradicate cancer Stem Cells.
Brown G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768694
[TBL] [Abstract] [Full Text] [Related]
4. Roles of Nuclear Receptors in Esophageal cancer.
Deng L; Liu J; Chen WD; Wang YD
Curr Pharm Biotechnol; 2023; 24(12):1489-1503. PubMed ID: 36740804
[TBL] [Abstract] [Full Text] [Related]
5. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
[TBL] [Abstract] [Full Text] [Related]
6. Synthetic Retinoids Beyond cancer Therapy.
Gudas LJ
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():155-175. PubMed ID: 34516292
[TBL] [Abstract] [Full Text] [Related]
7. Successful treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case.
Suzuki R; Kawai H; Furuya D; Akashi H; Ogawa Y; Kawada H; Ando K
Tokai J Exp Clin Med; 2020 Jul; 45(2):92-96. PubMed ID: 32602108
[TBL] [Abstract] [Full Text] [Related]
8. Potential role of CYP1B1 in the development and treatment of metabolic diseases.
Li F; Zhu W; Gonzalez FJ
Pharmacol Ther; 2017 Oct; 178():18-30. PubMed ID: 28322972
[TBL] [Abstract] [Full Text] [Related]
9. Radiolabeling and initial biological evaluation of [
Solingapuram Sai KK; Das BC; Sattiraju A; Almaguel FG; Craft S; Mintz A
Bioorg Med Chem Lett; 2017 Mar; 27(6):1425-1427. PubMed ID: 28216044
[TBL] [Abstract] [Full Text] [Related]
10. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract] [Full Text] [Related]
11. Screening Chemicals for Receptor-Mediated Toxicological and Pharmacological Endpoints: Using Public Data to Build Screening Tools within a KNIME Workflow.
Steinmetz FP; Mellor CL; Meinl T; Cronin MT
Mol Inform; 2015 Feb; 34(2-3):171-8. PubMed ID: 27490039
[TBL] [Abstract] [Full Text] [Related]
12. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.
Ferreira AK; Santana-Lemos BA; Rego EM; Filho OM; Chierice GO; Maria DA
Br J Cancer; 2013 Nov; 109(11):2819-28. PubMed ID: 24201752
[TBL] [Abstract] [Full Text] [Related]
13. Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer.
Rogenhofer S; Ellinger J; Kahl P; Stoehr C; Hartmann A; Engehausen D; Wieland WF; Müller SC; Hofstädter F; Walter B
Anticancer Res; 2012 Aug; 32(8):3479-83. PubMed ID: 22843934
[TBL] [Abstract] [Full Text] [Related]
14. Arsenic decreases RXRα-dependent transcription of CYP3A and suppresses immune regulators in hepatocytes.
Noreault-Conti TL; Fellows A; Jacobs JM; Trask HW; Strom SC; Evans RM; Wrighton SA; Sinclair PR; Sinclair JF; Nichols RC
Int Immunopharmacol; 2012 Apr; 12(4):651-6. PubMed ID: 22310326
[TBL] [Abstract] [Full Text] [Related]
15. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract] [Full Text] [Related]
16. Impact of intracellular alpha fetoprotein on retinoic acid receptors-mediated expression of GADD153 in human hepatoma cell lines.
Li C; Wang S; Jiang W; Li H; Liu Z; Zhang C; McNutt MA; Li G
Int J Cancer; 2012 Feb; 130(4):754-64. PubMed ID: 21365646
[TBL] [Abstract] [Full Text] [Related]
17. c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cells.
Hoshikawa Y; Kanki K; Ashla AA; Arakaki Y; Azumi J; Yasui T; Tezuka Y; Matsumi Y; Tsuchiya H; Kurimasa A; Hisatome I; Hirano T; Fujimoto J; Kagechika H; Shomori K; Ito H; Shiota G
Cancer Sci; 2011 May; 102(5):934-41. PubMed ID: 21272161
[TBL] [Abstract] [Full Text] [Related]
18. Massive ascites associated with all-trans retinoic acid treatment in therapy-related acute promyelocytic leukemia.
Suzukawa M; Nakazora T; Kawasaki Y; Tominaga T; Shinohara K
Intern Med; 2010; 49(5):457-60. PubMed ID: 20190483
[TBL] [Abstract] [Full Text] [Related]
19. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation.
Jung JK; Park SH; Jang KL
J Gen Virol; 2010 Feb; 91(Pt 2):493-500. PubMed ID: 19828754
[TBL] [Abstract] [Full Text] [Related]
20. beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes.
Sinha J; Chen F; Miloh T; Burns RC; Yu Z; Shneider BL
Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G996-G1003. PubMed ID: 18772362
[TBL] [Abstract] [Full Text] [Related]
[Next]
